Gallid herpesvirus 2 (ATCC® VR-2175)

Classification: Herpesviridae, Mardivirus  /  Product Format: frozen

Classification Herpesviridae, Mardivirus
Deposited As Marek's disease virus type 1
Agent Gallid herpesvirus 2
Strain Md11/75C/R2
Applications
Must be preserved in living cells to maintain viability (10% DMSO).
Must be preserved in living cells to maintain viability (10% DMSO).
Biosafety Level 2
Isolation
From MD11/75C strain of Marek's disease virus
Product Format frozen
Storage Conditions   Vapor phase of liquid nitrogen
Comments
Must be preserved in living cells to maintain viability (10% DMSO).
Virus is cell-associated. A vaccine strain derived from a CEF attenuated isolate of the Md11/75C Marek's disease virus isolate by passage in chickens to increase efficacy.
Must be preserved in living cells to maintain viability (10% DMSO).
Effect on Host
Yes, in vitro effects: Cytopathic effects (plaque formation, cell rounding) in chicken embryo fibroblasts
CPE (plaques, cell rounding)
Effect on Host
Yes, in vitro effects: Cytopathic effects (plaque formation, cell rounding) in chicken embryo fibroblasts
CPE (plaques, cell rounding)
Name of Depositor RL Witter
Source
From MD11/75C strain of Marek's disease virus
References

Witter RL. Revertant serotype 1 Marek's disease vaccine. US Patent 4,895,717 dated Jan 23 1990